For 2 years, physicians and scientists have puzzled over the cardiovascular complications from COVID-19, but new proteomics research is helping to shed light on some of the biological mechanisms driving this heightened risk.
In the study, which analyzed thousands of candidate proteins, investigators identified key pathways activated in patients with COVID-19-related myocardial injury, vascular thrombosis, and heart failure. Their findings suggest that the senescence-associated secretory phenotype (SASP), which is a marker of biological aging, may play a key role in COVID-19 disease severity and cardiac involvement. In addition, increased activin/TGF signaling, previously associated with heart failure, and the downregulation of the antithrombotic protein ADAMTS13, were the biological processes most strongly associated with myocardial stress and injury in COVID-19 patients.
Plasma proteomics enables us to measure levels of multiple proteins circulating in the blood, explained lead investigator Jason Roh, MD (Massachusetts General Hospital, Boston, MA). Using a technology developed by SomaLogic, we were able to measure almost 5,000 protein analytes in the blood of patients with COVID-19. Our goal with this initial study was to try to gain insights into why certain people develop cardiac complications with COVID-19 while others do not. Thats where we started. What it and the follow-up validation studies revealed to us was that there does seem to be specific biology underlying these cardiac complications that importantly could potentially be actionable.
The study, led by Roh and senior investigator Anthony Rosenzweig, MD (Massachusetts General Hospital), was performed during one of the first COVID-19 surges in the US, at a time when researchers were seeing a lot of infected patients hospitalized with accompanying cardiac complications. It just wasnt very clear why these things were happening, said Roh.
Senescence Cells and More
The first case-control proteomics study, which was published May 4, in JACC: Basic to Translational Science, included 80 adult patients (mean age 64 years; 41% women) with clinical biomarker and echocardiography data assessed for cardiac complications. Key findings were validated in a second cohort of 305 COVID-19 patients, in addition to an animal model of COVID-19.
The initial proteomics study was designed to discover how blood proteins differ in COVID-19 patients who experience cardiac complications versus those who do not. This included 26 healthy controls without COVID-19, 25 with moderate COVID-19, half of whom had cardiac complications and half who did not, and 29 patients with severe COVID-19, half of whom had low degrees of cardiac complications and half who had a high degree of cardiac complications. Moderate COVID-19 was defined as a hospitalization, while severe disease included hospitalized patients who required the ICU. Study subjects were matched based on age, sex, race, and comorbidities.
The researchers first looked to see what was different in the blood of COVID-19 patients compared to healthy, noninfected, controls. Although patients were of similar age, their initial analysis showed that the cellular senescence pathway, SASP, which is often viewed as a marker of aging cells, was the most highly enriched process in patients with COVID-19. Further analyses showed that it was also the most significantly upregulated process in COVID-19 patients with cardiac involvement. This finding was confirmed in the validation cohort.
One thing we often do in these large-scale proteomic studies is something called pathway analysis, which enables us to look for overarching biological processes potentially changing with disease, said Roh. Interestingly, the pathway that showed the most significant association with disease severity and cardiac complications in COVID-19 patients was the senescence-associated secretory phenotype. This is a collection of proteins secreted by senescent cells, or cells that have undergone an irreversible process of growth arrest and is often associated with aging. We know that older individuals tend to have more senescent cells, but also that really severe infections can induce senescence, too.
Indeed, a transcriptional profile of lungs from hamsters infected with SARS-CoV-2 also showed marked enrichment for SASP, a finding that confirms these age-related senescence genes can be turned on by SARS-CoV-2 infection.
Its interesting because if you take healthy, young animals and you infect them with SARS-CoV-2, you get this robust increase in SASP expression, said Roh. Its almost like theres a bidirectional relationship with COVID-19 and senescence. We think part of the reason why older individuals are at higher risk of severe disease and cardiac complications is that they probably have a higher burden of senescence at baseline. However, at the same time, the virus itself can actually trigger a senescence process, even in younger, healthier individuals. Whether these senescent cells persist after the initial infection and contribute to the syndrome of long COVID is unclear, but it is something being explored by multiple groups now.
In addition to broader pathway analyses, the researchers also looked to see which specific proteins were the most strongly associated with elevated levels of troponin T and NT-proBNP, established biomarkers used to assess myocardial injury and heart failure, respectively. Of the 4,996 protein analytes assayed, ADAMTS13 was the most significantly downregulated protein associated with troponin T, while FSTL3, a marker of increased activin/TGF signaling, was the most significantly upregulated protein associated with NT-proBNP.
Whats particularly interesting, said Roh, is that ADAMTS13 is a von Willebrand factor-cleaving protease whose loss-of-function is known to cause microvascular thrombosis, which is something we have seen in the hearts of COVID-19 patients with myocardial injury.
Target Pathways With Developing Therapies
For Roh, their study is exciting because the three biological processes make sense based on past research. Low ADAMTS13 levels have been causally implicated in microvascular thrombosis and occlusion, and increased activin/TGF signaling has also been previously implicated in heart failure studies.
Just as exciting is the prospect that these processes might be targeted with future therapies that could specifically address cardiovascular complications in COVID-19, and importantly, potentially improve outcomes for these patients. Recombinant ADAMTS13 and activin/TGF inhibitors are currently under development for other clinical indications, and could potentially be repurposed for COVID-19 if additional investigations in preclinical models prove them to be safe and efficacious.
Additionally, the role of senescence in different disease processes, including COVID-19, has been increasingly recognized. Researchers are beginning to test whether targeting senescent cells with drugs known as senolytics can improve outcomes in COVID-19. Most of this work is still in the preclinical stages, but some groups are beginning to test these senolytics in select patients, said Roh.
The rest is here:
The Hunt for Protein Culprits in COVID-19's Cardiac Complications - TCTMD
- Vascular Cell and Molecular Biology | Center for Vascular Biology | Weill Cornell ... - April 13th, 2018 [April 13th, 2018]
- APVBO-Asia Pacific Vascular Biology Organization Conference - April 18th, 2018 [April 18th, 2018]
- Vascular Biology Conferences | Vascular Surgery ... - May 5th, 2018 [May 5th, 2018]
- Vascular Discovery: From Genes to Medicine - May 7th, 2018 [May 7th, 2018]
- 2019 Vascular Cell Biology Conference GRC - May 26th, 2018 [May 26th, 2018]
- Biology 211: Taxonomy of Flowering Plants - June 7th, 2018 [June 7th, 2018]
- esm-evbo2019.org - Menu - July 27th, 2018 [July 27th, 2018]
- Vascular Biology | Pulmonary, Allergy, Sleep & Critical ... - November 16th, 2018 [November 16th, 2018]
- Lower vascular plant | biology | Britannica.com - November 18th, 2018 [November 18th, 2018]
- Vascular Biology - NAVBO - November 20th, 2018 [November 20th, 2018]
- 2019 Cerebral Vascular Biology Conference - cvent.com - November 21st, 2018 [November 21st, 2018]
- PPARs and Their Emerging Role in Vascular Biology ... - November 26th, 2018 [November 26th, 2018]
- Vascular Biology Chicago Medicine - November 30th, 2018 [November 30th, 2018]
- Vascular Biology | Society for Vascular Surgery - November 30th, 2018 [November 30th, 2018]
- Vascular Biology 2018 - NAVBO - December 19th, 2018 [December 19th, 2018]
- Vascular Biology 2019 - NAVBO - December 20th, 2018 [December 20th, 2018]
- Vascular Biology - January 22nd, 2019 [January 22nd, 2019]
- pvb2019.org Plant Vascular Biology Conference 2019 - January 31st, 2019 [January 31st, 2019]
- Plant Physiology | Basic Biology - March 12th, 2019 [March 12th, 2019]
- Awards - esm-evbo2019.org - April 23rd, 2019 [April 23rd, 2019]
- Medication and Exercise to Prevent Muscle Loss - Next Avenue - September 24th, 2019 [September 24th, 2019]
- A Snail as Fast as a Bullet, and Other Darwin-Defying Marvels - Discovery Institute - September 24th, 2019 [September 24th, 2019]
- Nature up close: Life in the Humboldt Penguin National Reserve - CBS News - September 24th, 2019 [September 24th, 2019]
- Oklahoma new hires and promotions announced - Oklahoman.com - September 24th, 2019 [September 24th, 2019]
- Quinn Capers IV, MD - TCTMD - September 24th, 2019 [September 24th, 2019]
- Cardiovascular Repair And Reconstruction Devices Market Global Industry Insights by Top Vendors, Growth, Revenue and Forecast Outlook 2019-2025 -... - September 26th, 2019 [September 26th, 2019]
- Four health projects at Boston Childrens Hospital that could help adults - The Boston Globe - September 30th, 2019 [September 30th, 2019]
- Research Officer/ Postdoctoral Researcher - The Conversation AU - October 16th, 2019 [October 16th, 2019]
- UNSW skin cancer researcher Levon Khachigian hit with string of retractions - ABC News - October 16th, 2019 [October 16th, 2019]
- Michal Wszola: We Expect to Transplant the Bioprinted Bionic Pancreas in Three to Five Years - 3DPrint.com - October 24th, 2019 [October 24th, 2019]
- 'The Blob': This mysterious 'smart' slime can solve puzzles and make decisions - CNBC - October 24th, 2019 [October 24th, 2019]
- University of Maryland and DOD collaborate to study Tick-borne Infections using 3-D models of human blood vessels - Outbreak News Today - November 19th, 2019 [November 19th, 2019]
- Submerged Vegetation Mirrors Coast's Health - Coastal Review Online - November 19th, 2019 [November 19th, 2019]
- Another health warning for e-cigarette users that has nothing to do with lung disease - MarketWatch - November 19th, 2019 [November 19th, 2019]
- E-Cigarettes Take a Dangerous Toll on Heart Health - DocWire News - November 19th, 2019 [November 19th, 2019]
- Vascular biology Department of Surgery College of ... - November 19th, 2019 [November 19th, 2019]
- US Nobel laureates tell us what they think about cancer research, moonshots, the dark side, funding, meritocracy, herd mentality, Trump, and joy - The... - November 21st, 2019 [November 21st, 2019]
- Growing Organs in the Lab: One Step Closer to Reality - BioSpace - November 21st, 2019 [November 21st, 2019]
- Inotrem Announces Enrollment of First Patient in its Phase IIb ASTONISH Trial for Nangibotide in the Treatment of Septic Shock - Business Wire - November 21st, 2019 [November 21st, 2019]
- Another Study Suggests E-cigarettes Hurt Heart Health More Than Regular Cigarettes - Science Times - November 21st, 2019 [November 21st, 2019]
- Cleveland Clinic awarded $12 million by NIH to study the link between gut microbes and heart disease - Crain's Cleveland Business - November 21st, 2019 [November 21st, 2019]
- JanOne Acquires Worldwide, Exclusive License for Promising Treatment of Peripheral Arterial Disease (PAD) - Yahoo Finance - November 27th, 2019 [November 27th, 2019]
- Germ-free lungs of newborn mice are partially protected against hyperoxia - The Mix - November 27th, 2019 [November 27th, 2019]
- Bethesda Health Physician Group Welcomes Fellowship-Trained Endocrine Surgeon Jessica L. Buicko, MD, to Its Team - The Boca Raton Tribune - November 27th, 2019 [November 27th, 2019]
- 9 Harvard researchers named AAAS Fellows Harvard - Harvard Gazette - November 27th, 2019 [November 27th, 2019]
- Top Technical Advances of 2019 - The Scientist - December 29th, 2019 [December 29th, 2019]
- Growing up Tyrannosaurus rex: Osteohistology refutes the pygmy Nanotyrannus and supports ontogenetic niche partitioning in juvenile Tyrannosaurus -... - January 2nd, 2020 [January 2nd, 2020]
- UCC currently taking applicants for 21 jobs with some incredible pay - Cork Beo - January 2nd, 2020 [January 2nd, 2020]
- Vascular Biology | Surgery Research | Michigan Medicine ... - January 2nd, 2020 [January 2nd, 2020]
- Sandy Bottom wetlands to receive protection for 'national ecological significance' - Citizen Times - January 14th, 2020 [January 14th, 2020]
- Why biotech is a boon for patients and investors - Spear's WMS - January 14th, 2020 [January 14th, 2020]
- Exonate Announces Collaboration With Janssen to Develop a New Eye Drop for the Treatment of Retinal Vascular Diseases Including Wet Age-related... - January 14th, 2020 [January 14th, 2020]
- G-protein Coupled Receptor Market Competitive Research And Precise Outlook 2019 To 2025 Dagoretti News - Dagoretti News - January 18th, 2020 [January 18th, 2020]
- Scientists revealed the oldest known scorpion on Earth - Tech Explorist - January 18th, 2020 [January 18th, 2020]
- How biology creates networks that are cheap, robust, and efficient - Penn: Office of University Communications - January 18th, 2020 [January 18th, 2020]
- Genome editing heralds new era of disease research, therapy - The Augusta Chronicle - January 18th, 2020 [January 18th, 2020]
- Research Fellow in Vascular Stem Cell Biology job with QUEENS UNIVERSITY BELFAST | 195527 - Times Higher Education (THE) - February 10th, 2020 [February 10th, 2020]
- More than skin deep: the latest innovation in 3D printing - Med-Tech Innovation - February 10th, 2020 [February 10th, 2020]
- Examining the link between menopause and heart disease risk - Medical News Bulletin - February 10th, 2020 [February 10th, 2020]
- Women Face an Increased Risk of Heart Disease With AgeRunning Can Help - runnersworld.com - February 12th, 2020 [February 12th, 2020]
- G-protein Coupled Receptor Market Competitive Research And Precise Outlook 2019 To 2025 - Galus Australis - February 15th, 2020 [February 15th, 2020]
- Valentine's Day Matters of the Heart, Biopharma-Style - BioSpace - February 15th, 2020 [February 15th, 2020]
- The Addicted Gardener: Environmental tidbits from around the world - Wicked Local Sharon - February 22nd, 2020 [February 22nd, 2020]
- UI at 150 & Beyond: 'The Quad was the best no matter what the weather' - Champaign/Urbana News-Gazette - February 22nd, 2020 [February 22nd, 2020]
- The Addicted Gardener: Environmental tidbits from around the world - Wicked Local Dedham - February 23rd, 2020 [February 23rd, 2020]
- THE ADDICTED GARDENER: Environmental tidbits from around the world - Wicked Local Wareham - March 22nd, 2020 [March 22nd, 2020]
- 'Little Foot' skull reveals how this more than 3 million year old human ancestor lived - HeritageDaily - March 22nd, 2020 [March 22nd, 2020]
- It's Not Only About Neurons - The Good Men Project - March 22nd, 2020 [March 22nd, 2020]
- Who is Sir Patrick Vallance and what is his role in government during coronavirus outbreak? - The Scottish Sun - March 22nd, 2020 [March 22nd, 2020]
- University of Washington Pathology Professor Dies of COVID-19 - The Scientist - March 22nd, 2020 [March 22nd, 2020]
- THE ADDICTED GARDENER: Environmental tidbits from around the world - Wicked Local Rochester - March 23rd, 2020 [March 23rd, 2020]
- Ancient human ancestor 'Little Foot' probably lived in trees, new research finds - WBAP News/Talk - March 23rd, 2020 [March 23rd, 2020]
- Study shows similarity in anti-VEGF injection intervals for wet AMD - Ophthalmology Times - March 25th, 2020 [March 25th, 2020]
- aTyr Pharma and its Hong Kong Subsidiary, Pangu BioPharma, Announce Government Grant to Fund Bispecific Antibody Development Platform - BioSpace - March 25th, 2020 [March 25th, 2020]
- Health researchers find solution to life-threatening side effect - Mirage News - March 25th, 2020 [March 25th, 2020]
- European Vascular Biology Organisation | Advancing human ... - March 25th, 2020 [March 25th, 2020]
- Vascular Biology Program | Boston Children's Hospital - March 25th, 2020 [March 25th, 2020]
- Vascular Biology Research Program | Johns Hopkins ... - March 25th, 2020 [March 25th, 2020]
- Anatomy of a heatwave: how Antarctica recorded a 20.75C day last month - The Conversation AU - April 1st, 2020 [April 1st, 2020]
- Who is Sir Patrick Vallance and is he speaking at todays government coronavirus press briefing? - The Sun - April 1st, 2020 [April 1st, 2020]